UNC Health Medication Formulary
Add Formweb to your mobile device
System Formulary Update
Triamcinolone Acetonide Suprachoroidal (Xipere)
January 1, 1970
Situation
The formulary addition proposal for triamcinolone acetonide injectable suspension for suprachoroidal use (Xipere) was approved at the May 2022 System P&T Committee meeting.
Background
The following medications were reviewed via a medication use evaluation: triamcinolone acetonide suprachoroidal (Xipere)
Assessment/Recommendation
Change effective: Tuesday, July 19th
System P&T voted to include the following products on the UNC Health Medication Formulary:
- triamcinolone acetonide injectable suspension